Key Drivers
- High returns
- Debt leverage
- Volatile earnings
AIAI Summary
SOLV is now an execution‑sensitive turnaround and capital‑returns story: the investment case rests on delivering the $500M Transform savings and converting divestiture proceeds into recurring $450–$550M free cash flow—if achieved, buybacks and deleveraging should re-rate the stock, but failure (or tariff/input cost shocks and impairment risk) would quickly undermine equity given high net debt and large intangibles.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High returns
- •Debt leverage
- •Volatile earnings
SOLV shows strong profitability and inexpensive multiples (ROE ~37%, gross margin ~54%, P/E ~8.3) but carries material solvency and cash-flow risk from heavy intangibles, ~ $5.0bn long-term debt and FY negative FCF amid volatile quarterly earnings.
Price Behavior
Key Price Behavior Insights:
- •Below last-month SMA
- •14–15% pullback
- •Support at lows
SOLV is in a short-term downtrend trading below its last-month SMA (~$70.10), having pulled back ~14–15% to $65.78 and sitting on support around $66.12–$66.76 with resistance near $70.10 then $72.90–$76.90.
14–15% decline from $76.94 on 2026-02-26 to $65.78 on 2026-03-20
Sentiment & News
Key News Insights:
- •Margin pressure
- •Portfolio reshaping
- •Cost-savings plan
Solventum reported modest organic growth and top-line beats but faces margin pressure amid a large divestment, a $500M cost-savings plan, active investor outreach, and SOLV Energy's strong IPO/backlog update.
The push to monetize assets and cut costs should stabilize cash flow but margin headwinds and near-term guidance limit upside for the stock
Similar Companies in Healthcare
Other companies in the same sector with AI ratings